INJE UNIVERSITY
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1979-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.inje.ac.kr
Clinical Trials
136
Active:6
Completed:82
Trial Phases
5 Phases
Phase 1:7
Phase 2:2
Phase 3:12
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (118 trials with phase data)• Click on a phase to view related trials
Not Applicable
84 (71.2%)Phase 4
13 (11.0%)Phase 3
12 (10.2%)Phase 1
7 (5.9%)Phase 2
2 (1.7%)App-based Education Program for CKD
Not Applicable
Active, not recruiting
- Conditions
- Renal Insufficiency, Chronic
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Inje University
- Target Recruit Count
- 129
- Registration Number
- NCT05766644
- Locations
- 🇰🇷
Inje University Seoul Paik Hospital, Seoul, Korea, Republic of
Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature.
Not Applicable
Completed
- Conditions
- Urologic Diseases
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Inje University
- Target Recruit Count
- 50
- Registration Number
- NCT05636189
- Locations
- 🇰🇷
Sanggye paik hospital, Seoul, Korea, Republic of
Effect of Remimazolam and Propofol on Postoperative Delirium
Not Applicable
Recruiting
- Conditions
- Knee OsteoarthritisHip FracturesFemur Fracture
- Interventions
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Inje University
- Target Recruit Count
- 82
- Registration Number
- NCT05514405
- Locations
- 🇰🇷
Sanggye Paik hospital, Seoul, Korea, Republic of
Adaptive Nutrition Therapy in Hemodialysis
Not Applicable
Completed
- Conditions
- Renal Dialysis
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Inje University
- Target Recruit Count
- 175
- Registration Number
- NCT05469620
- Locations
- 🇰🇷
Inje University Seoul Paik Hospital, Seoul, Korea, Republic of
Effect of Remimazolam on Postoperative Nausea and Vomiting
Not Applicable
Completed
- Conditions
- Postoperative Nausea and Vomiting
- Interventions
- Drug: Control
- First Posted Date
- 2022-06-30
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Inje University
- Target Recruit Count
- 108
- Registration Number
- NCT05439057
- Locations
- 🇰🇷
Sanggye Paik hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
News
No news found